SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-17-027234
Filing Date
2017-04-28
Accepted
2017-04-28 07:06:31
Documents
2
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A a17-11890_3defa14a.htm DEFA14A 29408
2 GRAPHIC g118903bci001.gif GRAPHIC 117317
  Complete submission text file 0001104659-17-027234.txt   192122
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37508 | Film No.: 17791638
SIC: 2834 Pharmaceutical Preparations